Evidence map›Paper›PMID 38549368›Full record

SynthesisJournal of pediatric hematology/oncology nursing

Evidence-Based Recommendations for Education Provided to Patients and Families Regarding the Adverse Events of ALK and MEK Inhibitors: A Systematic Review From the Children's Oncology Group.

Beth Fisher, Ashley Meyer, Anastasia Brown, Mary Conway Keller, Tara McKeown, Jennifer Tiller, Kate M Saylor, Elizabeth A Duffy

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Journal of pediatric hematology/oncology nursing. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

Beth FisherAugusta University College of Nursing, Augusta University-Children's Hospital of Georgia, Augusta, GA, USA.ORCID 0000-0001-6678-7035
Ashley MeyerSt. Louis Children's Hospital, Washington University School of Medicine, St Louis, MO, USA.ORCID 0009-0006-4887-1579
Anastasia BrownChildren's Minnesota, Minneapolis, MN, USA.
Mary Conway KellerConnecticut Children's, Hartford, CT, USA.ORCID 0000-0001-8011-8014
Tara McKeownHospital for Sick Children, Toronto, Canada.
Jennifer TillerAscension Dell Children's, Austin, TX, USA.
Kate M SaylorThe University of Michigan, Ann Arbor, MI, USA.
Elizabeth A DuffyThe University of Michigan School of Nursing, Ann Arbor, MI, USA.ORCID 0000-0001-5038-803X
University of Michigan · USAugusta University · USConnecticut Children's Medical Center · USDell Children's Medical Center of Central Texas · USHospital for Sick Children · CAMinnesota West Community & Technical College · USSt. Louis Children's Hospital · US

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
NCI NIH HHS U10 CA180886
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsNeoplasmsAnaplastic Lymphoma KinaseChildHumansMitogen-Activated Protein Kinase KinasesProtein Kinase InhibitorsAnaplastic Lymphoma KinaseAntineoplastic AgentsMitogen-Activated Protein Kinase KinasesProtein Kinase Inhibitorsadverse eventsALK inhibitorseducationMEK inhibitorspediatrictargeted therapy

Identifiers

PMID38549368
PMCPMC11145517
OpenAlexW4393314170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.